Changzhou

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

State-of-the-art facility expands WuXi STA's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial …

4 years ago

LANXESS to build new production plant for high-performance plastics in Krefeld-Uerdingen, Germany

Cologne, November 18, 2018: Specialty chemicals company LANXESS is continuing to invest in its global production network for high-performance plastics and…

6 years ago

WuXi STA Changzhou Site Passes First U.S. FDA Inspection

The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval Shanghai, May 11,…

6 years ago

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA. Shanghai, May 03, 2018: STA…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420